T. Rasmussen et al., Frequency and kinetics of polyclonal and clonal B cells in the peripheral blood of patients being treated for multiple myeloma, BLOOD, 96(13), 2000, pp. 4357-4359
Recent studies concerning the numbers of circulating clonal B cells in pati
ents with multiple myeloma (MM) have reported conflicting data regarding th
e exact level and phenotype of clonal B cells and their response to treatme
nt. In this report we document that the peripheral blood tumor burden at pr
esentation was reduced by induction therapy to a low level, regardless of t
he initial tumor burden. However, the residual clonal compartment persisted
before and after transplant. The level of clonal cells showed no correlati
on with CD19(+) cell levels. In a single patient with MM, high numbers of p
henotypically aberrant clonal cells with altered CD19 expression were ident
ified. (Blood. 2000;96:4357-4359) (C) 2000 by The American Society of Hemat
ology.